Blog

Patrick Forde: Presented data on adjuvant immunotherapy at WCLC2024 to help guide management of lung cancer

Photo of Patrick Forde/Facebook

Sep 14, 2024, 06:23

Patrick Forde: Presented data on adjuvant immunotherapy at WCLC2024 to help guide management of lung cancer

Patrick Forde, Professor at the Johns Hopkins University, posted the following on LinkedIn:

“In the presidential session at the World Conference on Lung Cancer today, WCLC2024, I presented data to help guide use of adjuvant immunotherapy after neoadjuvant chemo-immunotherapy for lung cancer. This is a key clinical question in management of lung cancer, and these data may help guide management in near future.”

Source: Patrick Forde/LinkedIn

adjuvant immunotherapy cancer Cancer Management Cancer research clinical data immunotherapy Johns Hopkins University Lung cancer lung cancer treatment neoadjuvant chemo-immunotherapy OncoDaily Oncology Patrick Forde WCLC2024 World Conference on Lung Cancer

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage